Eli Lilly raises revenue outlook on weight-loss drug sales, trims profit view

Eli Lilly lifted its revenue forecast on strong weight-loss drug sales but lowered its profit outlook due to deal charges, according to Reuters. Coverage ahead of earnings also flagged the company as a key pharma report to watch.

Timeline

1. 29 Oct, 10:50 UTCFirst appeared on Google Trends
2. 29 Oct, 10:50 UTCPicked up on News
3. 29 Oct, 10:50 UTCReuters reports revenue outlook raise and profit cut

Top sources

• lly stockGoogle Trends
• 3 Big Pharma Earnings Reports to Watch: Eli Lilly, Merck and GileadYahoo Finance
• Lilly reports third-quarter 2026 financial results, raises full-year guidance and highlights regulatory progress across the portfolioEli Lilly
• Lilly Raises Sales Guidance, Widening Its Lead in Obesity MarketBloomberg
• We're raising our price target on Eli Lilly as the obesity-drug boom rolls onCNBC
• Eli Lilly lifts revenue outlook on weight-loss drug sales, trims profit view on deal chargesReuters